Page last updated: 2024-08-24

telmisartan and Left Ventricular Hypertrophy

telmisartan has been researched along with Left Ventricular Hypertrophy in 41 studies

Research

Studies (41)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (2.44)	18.2507
2000's	19 (46.34)	29.6817
2010's	20 (48.78)	24.3611
2020's	1 (2.44)	2.80

Authors

Authors	Studies
Cai, Y; Chang, D; Ju, S; Lu, CQ; Min, SD; Wang, YC; Xu, TT; Zhang, SJ; Zhao, Z	1
Guan, G; Ma, A; Shao, L; Tian, G; Wang, J; Wang, Y; Zhang, Y	1
Hirooka, Y; Kishi, T; Sunagawa, K	1
Böhm, M; Foulquier, S; Schmieder, R; Schumacher, H; Sleight, P; Teo, K; Unger, T; Yusuf, S	1
Frohlich, ED; Susic, D	1
Chen, L; Hong, H; Lin, X; Shi, X; Wu, Y; Zou, G	1
Abdulzahra, MS; Al-Aubaidy, HA; Al-Huseini, LM; Hadi, NR	1
Fujimoto, Y; Hinoi, T; Kajiwara, S; Matsuo, S; Ono, T; Shichijo, T; Tomohiro, Y; Yamamoto, S	1
Brazhnik, VA; Makolkin, VI; Petriĭ, VV; Sergushkina, NG	1
Elisaf, MS; Liberopoulos, EN; Rizos, CV	1
Chen, JH; Fagard, R; Gao, P; Jansky, P; Jennings, G; Kim, JH; Liu, L; Mancia, G; Probstfield, J; Schmieder, RE; Sleight, P; Teo, K; Trimarco, B; Verdecchia, P; Yusuf, S	1
Anderson, C; Cowan, BR; Doughty, RN; Jennings, GL; Krittayaphong, R; Lonn, E; Marwick, TH; Reid, CM; Sanderson, JE; Schmieder, RE; Teo, K; Wadham, AK; Worthley, SG; Young, AA; Yu, CM; Yusuf, S	1
Antonelli, A; Carpi, A; Fallahi, P; Franzoni, F; Galetta, F; Graci, F; Santoro, G; Tocchini, L	1
Ara, N; Iuchi, A; Miyoshi, H; Mizuguchi, Y; Nagase, N; Oishi, Y; Oki, T	1
Di Lorenzo, A; Kauser, K; Krieger, MH; Sessa, WC; Teutsch, C	1
Gao, J; Liu, L; Ma, L; Meng, X; Wang, L; Wang, P; Wang, W; Wu, H; Wu, W; Zhang, W	1
Dellsperger, KC; DeMarco, VG; Gul, R; Habibi, J; Hayden, MR; Johnson, MS; Pulakat, L; Sowers, JR; Tilmon, RD; Whaley-Connell, AT; Winer, N	1
Jugdutt, BI	1
Ge, JB; Guan, AL; Li, JM; Liang, YY; Ma, Z; Mi, SL; Wu, J; Yao, ZF; Zou, YZ	1
Guan, HS; Meng, XM; Qiao, SB; Shang, Z; Shangguan, HJ; Yang, L	1
Hasegawa, H; Kobayashi, Y; Komuro, I; Mizuguchi, T; Namiki, T; Narumi, H; Ohtsuka, M; Takano, H	1
He, WK; He, ZC; Lai, Q; Liang, LY; Lu, DF; Luo, JD; Pan, XD; Wang, W; Wen, YH; Xiao, AY; Zeng, ZH	1
Cagnoni, F; Cavalleri, C; Destro, M; Dognini, GP; Galimberti, V; Galli, E; Taietti, C	1
Binbrek, AS; Chazova, I; Dagenais, G; Dans, AL; Ferreira, R; Gao, P; Healey, J; Holwerda, N; Iacobellis, G; Karatzas, N; Keltai, M; Mancia, G; Sleight, P; Teo, K; Verdecchia, P; Yusuf, S	1
Hirata, Y; Hishikari, K; Isobe, M; Masumura, M; Nagai, R; Nagashima, A; Ogawa, M; Shimizu, T; Suzuki, J; Takayama, K; Watanabe, R	1
Kikuchi, T; Kimura, H; Mitsuhashi, T; Otsuka, K; Tsuchida, Y; Watanabe, Y	1
Chernova, NA; Fomicheva, OA; Ivanova, OV; Karpov, YA; Rogoza, AN; Sergakova, LM	2
Breglio, R; Capogrosso, P; Cerciello, A; Galzerano, D; Lama, D; Mallardo, M; Tammaro, P; Tuccillo, B	1
Dahlöf, B; Dietz, R; Friedrich, MG; Knecht, M; Sechtem, U; Unger, T	1
Bonatti, S; Bonetti, L; Mattioli, AV; Mattioli, G; Zennaro, M	1
Conrady, AO; Kiselev, IO; Krutikov, AN; Ovchinnikova, OA; Panov, AV; Polunicheva, EV; Usachev, NI; Yakovleva, OI	1
Anderson, C	1
Bonatti, S; Mattioli, AV; Mattioli, G; Monopoli, D; Zennaro, M	1
Breglio, R; Capogrosso, P; del Viscovo, L; Galzerano, A; Galzerano, D; Lama, D; Paolisso, G; Tammaro, P; Tuccillo, B	1
Devereux, RB; Krauser, DG	1
Goyal, BR; Goyal, RK; Mehta, AA; Mesariya, P	1
Fukushima, H; Hirata, H; Kobayashi, N; Machida, Y; Mamada, Y; Matsuoka, H; Nomura, M; Ohno, T; Shinoda, M; Suzuki, N; Yoshida, K	1
Zanchetti, A	1

Reviews

5 review(s) available for telmisartan and Left Ventricular Hypertrophy

Article	Year
Are the pleiotropic effects of telmisartan clinically relevant? Current pharmaceutical design, 2009, Volume: 15, Issue:24 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Body Fat Distribution; Cholesterol, LDL; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Glucose; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Kidney; PPAR gamma; Randomized Controlled Trials as Topic; Telmisartan	2009
Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly. Clinical interventions in aging, 2010, Dec-03, Volume: 5 Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Comorbidity; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Polypharmacy; PPAR gamma; Prevalence; Renin-Angiotensin System; Sex Factors; Stroke; Telmisartan	2010
Telmisartan: just an antihypertensive agent? A literature review. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:17 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrial Fibrillation; Benzimidazoles; Benzoates; Costs and Cost Analysis; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Diseases; Renin-Angiotensin System; Telmisartan	2011
Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Herz, 2006, Volume: 31, Issue:4 Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan	2006
Impact of hypertension and antihypertensive treatment on organ damage. The American journal of cardiology, 1999, Jul-22, Volume: 84, Issue:2A Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Carotid Stenosis; Cause of Death; Clinical Trials as Topic; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Survival Rate; Telmisartan; Treatment Outcome	1999

Trials

20 trial(s) available for telmisartan and Left Ventricular Hypertrophy

Article	Year
Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis. Journal of hypertension, 2014, Volume: 32, Issue:6 Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Cardiovascular System; Coronary Artery Disease; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Telmisartan; Treatment Outcome	2014
A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril. International journal of cardiology, 2017, Mar-01, Volume: 230 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Echocardiography, Doppler; Enalapril; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Retrospective Studies; Single-Blind Method; Telmisartan; Treatment Outcome; Ventricular Function, Left	2017
Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:4 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Coronary Circulation; Echocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Insulin Resistance; Lipids; Male; Microcirculation; Middle Aged; Telmisartan	2008
[Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients]. Terapevticheskii arkhiv, 2008, Volume: 80, Issue:12 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Echocardiography; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Organ Size; Telmisartan; Time Factors; Tunica Intima; Ventricular Remodeling	2008
Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Circulation, 2009, Oct-06, Volume: 120, Issue:14 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Cardiovascular Diseases; Diastole; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Electrocardiography; Female; Humans; Hypertrophy, Left Ventricular; Male; Odds Ratio; Placebos; Prevalence; Proportional Hazards Models; Ramipril; Regression Analysis; Systole; Telmisartan	2009
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET]). The American journal of cardiology, 2009, Dec-01, Volume: 104, Issue:11 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Atherosclerosis; Benzimidazoles; Benzoates; Diabetes Complications; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Ramipril; Survival Analysis; Telmisartan; Treatment Outcome; Ventricular Dysfunction, Left	2009
Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Autonomic Nervous System; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular System; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Parasympathetic Nervous System; Telmisartan; Treatment Outcome	2010
Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients. Hypertension research : official journal of the Japanese Society of Hypertension, 2011, Volume: 34, Issue:11 Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Benzimidazoles; Benzoates; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Follow-Up Studies; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Japan; Losartan; Male; Middle Aged; Prospective Studies; Risk Factors; Severity of Illness Index; Single-Blind Method; Telmisartan; Treatment Outcome	2011
The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension. Clinical and experimental hypertension (New York, N.Y. : 1993), 2011, Volume: 33, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Lipids; Male; Simvastatin; Telmisartan; Treatment Outcome; Ultrasonography; Ventricular Function, Left	2011
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtoleran Journal of hypertension, 2012, Volume: 30, Issue:5 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anthropometry; Atrial Fibrillation; Benzimidazoles; Benzoates; Body Mass Index; Cardiovascular Diseases; Diabetes Complications; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Middle Aged; Placebos; Ramipril; Risk; Risk Factors; Stroke; Telmisartan; Vitamin K	2012
Administration of angiotensin receptor II blockade improves vascular function, urinary albumin excretion, and left ventricular hypertrophy in low-risk essential hypertensive patients receiving antihypertensive treatment with calcium channel blockers. Clinical and experimental hypertension (New York, N.Y. : 1993), 2013, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Middle Aged; Risk Factors; Sodium Chloride; Telmisartan; Treatment Outcome	2013
[Angiotensin II receptor blocker telmisartan: effect on 24-hour blood pressure profile and left ventricular hypertrophy in patients with hypertension]. Kardiologiia, 2002, Volume: 42, Issue:2 Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Circadian Rhythm; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Receptors, Angiotensin; Telmisartan	2002
Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study. Journal of human hypertension, 2004, Volume: 18, Issue:1 Topics: Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Echocardiography, Three-Dimensional; Female; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Telmisartan; Treatment Outcome	2004
Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2003, Volume: 4, Issue:4 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Metoprolol; Middle Aged; Research Design; Telmisartan; Treatment Outcome	2003
Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan. International journal of cardiology, 2004, Volume: 97, Issue:3 Topics: Benzimidazoles; Benzoates; Diastole; Female; Humans; Hypertrophy, Left Ventricular; Male; Prospective Studies; Systole; Telmisartan; Ultrasonography	2004
Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension. The Journal of international medical research, 2005, Volume: 33 Suppl 1 Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Pressure; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Monitoring, Ambulatory; Telmisartan; Time Factors	2005
Effect of 24-week treatment with telmisartan on myocardial structure and function: relationship to insertion/deletion polymorphism of the angiotensin-converting enzyme gene. The Journal of international medical research, 2005, Volume: 33 Suppl 1 Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Echocardiography, Doppler; Female; Gene Deletion; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardium; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Telmisartan; Time Factors	2005
Rationale and design of the cardiac magnetic resonance imaging substudy of The ONTARGET Trial Programme. The Journal of international medical research, 2005, Volume: 33 Suppl 1 Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Middle Aged; Natriuretic Peptide, Brain; Patient Selection; Ramipril; Research Design; Telmisartan; Time Factors	2005
Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension. Blood pressure, 2005, Volume: 14, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Atrial Function, Left; Benzimidazoles; Benzoates; Echocardiography, Doppler, Color; Female; Heart Atria; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Telmisartan	2005
Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. American journal of hypertension, 2005, Volume: 18, Issue:12 Pt 1 Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Carvedilol; Circadian Rhythm; Echocardiography, Three-Dimensional; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Propanolamines; Telmisartan	2005

Other Studies

16 other study(ies) available for telmisartan and Left Ventricular Hypertrophy

Article	Year
Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction. Experimental biology and medicine (Maywood, N.J.), 2021, Volume: 246, Issue:23 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cardio-Renal Syndrome; Diastole; Disease Models, Animal; Echocardiography; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Rats; Rats, Sprague-Dawley; Renal Insufficiency, Chronic; Stroke Volume; Telmisartan; Ventricular Function, Left; Ventricular Remodeling	2021
Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway. Hypertension research : official journal of the Japanese Society of Hypertension, 2014, Volume: 37, Issue:1 Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blotting, Western; Collagen; Echocardiography; Fibrosis; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Telmisartan; Transforming Growth Factor beta1	2014
Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure. American journal of hypertension, 2014, Volume: 27, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Medulla Oblongata; Norepinephrine; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Telmisartan; Tetrazoles; Ventricular Function, Left	2014
Telmisartan improves survival and ventricular function in SHR rats with extensive cardiovascular damage induced by dietary salt excess. Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Body Weight; Diastole; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Male; Random Allocation; Rats, Inbred SHR; Sodium, Dietary; Telmisartan; Ventricular Dysfunction	2014
TRPC1, CaN and NFATC3 signaling pathway in the pathogenesis and progression of left ventricular hypertrophy in spontaneously hypertensive rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2015, Volume: 37, Issue:3 Topics: Amlodipine; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Disease Models, Animal; Disease Progression; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Male; NFATC Transcription Factors; Rats; Rats, Inbred SHR; Signal Transduction; Telmisartan; TRPC Cation Channels	2015
Possible mechanisms of left ventricular torsion evaluated by cardioreparative effects of telmisartan in patients with hypertension. European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology, 2010, Volume: 11, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Echocardiography; Feasibility Studies; Female; Fibrosis; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Statistics as Topic; Stroke Volume; Telmisartan; Ventricular Function, Left	2010
Telmisartan regresses left ventricular hypertrophy in caveolin-1-deficient mice. Laboratory investigation; a journal of technical methods and pathology, 2010, Volume: 90, Issue:11 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caveolin 1; Gene Expression Regulation; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 2; Telmisartan	2010
Left ventricular hypertrophy induced by abdominal aortic banding and its prevention by angiotensin receptor blocker telmisartan--a proteomic analysis. Journal of physiology and biochemistry, 2010, Volume: 66, Issue:4 Topics: Angiotensin Receptor Antagonists; Animals; Aorta; Aorta, Abdominal; Benzimidazoles; Benzoates; Blood Pressure; Echocardiography; Electrophoresis, Gel, Two-Dimensional; Heart Failure; Hypertrophy, Left Ventricular; Male; Proteomics; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Telmisartan	2010
Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat. American journal of physiology. Heart and circulatory physiology, 2011, Volume: 300, Issue:1 Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Body Weight; Heart; Heart Function Tests; Hypertrophy, Left Ventricular; Imidazoles; Janus Kinase 2; Male; Myocardium; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin-Angiotensin System; Telemetry; Telmisartan; Tetrazoles	2011
The therapeutic potential of G-CSF in pressure overload induced ventricular reconstruction and heart failure in mice. Molecular biology reports, 2012, Volume: 39, Issue:1 Topics: Animals; Benzimidazoles; Benzoates; Blotting, Western; Carotid Arteries; Constriction; DNA Primers; Echocardiography; Granulocyte Colony-Stimulating Factor; Heart Failure; Hypertension; Hypertrophy, Left Ventricular; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Microtubules; Reverse Transcriptase Polymerase Chain Reaction; Telmisartan; Vascular Endothelial Growth Factor A	2012
Endoplasmic reticulum stress caused by left ventricular hypertrophy in rats: effects of telmisartan. The American journal of the medical sciences, 2011, Volume: 342, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Benzimidazoles; Benzoates; Disease Models, Animal; Endoplasmic Reticulum; Fibrosis; Hemodynamics; Hypertrophy, Left Ventricular; Male; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Stress, Physiological; Telmisartan	2011
Different roles of PPAR-γ activity on physiological and pathological alteration after myocardial ischemia. Journal of cardiovascular pharmacology, 2012, Volume: 60, Issue:2 Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Calcium Channel Blockers; Cells, Cultured; Disease Models, Animal; Drug Partial Agonism; Fibrosis; Hypertrophy, Left Ventricular; Male; Matrix Metalloproteinase 2; Myocardial Infarction; Myocardium; Pioglitazone; PPAR gamma; Rats; Rats, Sprague-Dawley; Stroke Volume; Telmisartan; Thiazolidinediones; Time Factors; Ventricular Function, Left; Ventricular Remodeling	2012
[Improved protection of heart and kidneys in the hypertensive patient. ACE inhibitor and AT1 blocker combined?]. MMW Fortschritte der Medizin, 2003, Jun-05, Volume: 145, Issue:23 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Hypertrophy, Left Ventricular; Ramipril; Renal Insufficiency; Telmisartan	2003
[Normal blood pressure values in general practice are not enough. Also measure "morning after" values]. MMW Fortschritte der Medizin, 2004, May-06, Volume: 146, Issue:19 Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Benzoates; Circadian Rhythm; Coronary Disease; Drug Administration Schedule; Humans; Hypertension; Hypertrophy, Left Ventricular; Telmisartan; Treatment Outcome	2004
Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats. Molecular and cellular biochemistry, 2008, Volume: 314, Issue:1-2 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Female; Heart Rate; Hypertrophy, Left Ventricular; Models, Biological; Rats; Rats, Wistar; Streptozocin; Telmisartan	2008
Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. American journal of hypertension, 2008, Volume: 21, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Collagen Type I; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Plasminogen Activator Inhibitor 1; PPAR gamma; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Inbred Dahl; Research Design; rho-Associated Kinases; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sodium Chloride, Dietary; Superoxides; Telmisartan; Transcription Factor RelA; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Ventricular Remodeling	2008